Literature DB >> 18160068

Calcium homeostasis: reassessment of the actions of parathyroid hormone.

Roy V Talmage1, H T Mobley.   

Abstract

The purpose of this report is to adjust our interpretation of the actions of parathyroid hormone (PTH) to include its action on the bone mineral-noncollagenous protein interactions at all bone surfaces. The three primary areas that respond to PTH are: (1) all bone surface areas in contact with the extracellular fluid (ECF), (2) the kidney, and indirectly the intestinal tract, and (3) the bone remodeling sequence. The primary rapid action of the hormone is to set and maintain the free calcium concentration of the ECF. This it does by raising the equilibrium level at bone mineral surfaces. It affects the noncollagenous protein bone mineral process to raise the free calcium level in the ECF from the base level of 3.5mg/100ml to the physiological level of 5.0mg/100ml. Maintaining the higher level requires continuous secretion of parathyroid hormone. The action of PTH at bone surfaces tends to be catabolic in nature in regard to bone loss. The hormone also acts on the kidney to raise the threshold for calcium reabsorption and by stimulation of renal hydroxylation of vitamin D to increase intestinal absorption of calcium. Its action here is to supply the ECF with calcium derived from food intake. This is the extent of PTH action on renal processes. PTH acts on all three steps in the bone remodeling process. While its total function here is not clear, the result is a net increase in the synthesis of collagen. The report concludes by comparing the actions of PTH as proposed here to the functions of PTH that have been proposed in the past.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160068     DOI: 10.1016/j.ygcen.2007.11.003

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  12 in total

Review 1.  Osteocyte regulation of bone mineral: a little give and take.

Authors:  G J Atkins; D M Findlay
Journal:  Osteoporos Int       Date:  2012-08       Impact factor: 4.507

2.  Application of the logic of cysteine-free native chemical ligation to the synthesis of Human Parathyroid Hormone (hPTH).

Authors:  Shiying Shang; Zhongping Tan; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

Review 3.  The effects of smoking on bone metabolism.

Authors:  V Yoon; N M Maalouf; K Sakhaee
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

4.  Engineering of therapeutic polypeptides through chemical synthesis: early lessons from human parathyroid hormone and analogues.

Authors:  Suwei Dong; Shiying Shang; Jianfeng Li; Zhongping Tan; Thomas Dean; Akira Maeda; Thomas J Gardella; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2012-08-29       Impact factor: 15.419

5.  trpm7 regulation of in vivo cation homeostasis and kidney function involves stanniocalcin 1 and fgf23.

Authors:  Michael R Elizondo; Erine H Budi; David M Parichy
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

6.  Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.

Authors:  Manabu Okada; Yoshihiro Tominaga; Tetsuhiko Sato; Toshihide Tomosugi; Kenta Futamura; Takahisa Hiramitsu; Toshihiro Ichimori; Norihiko Goto; Shunji Narumi; Takaaki Kobayashi; Kazuharu Uchida; Yoshihiko Watarai
Journal:  BMC Nephrol       Date:  2022-06-17       Impact factor: 2.585

7.  Treatment of eggshell with casein phosphopeptide reduces the severity of ovariectomy-induced bone loss.

Authors:  Jung-Hoon Kim; Min Seuk Kim; Hong-Geun Oh; Hak-Yong Lee; Jeong-Woo Park; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Eun-Hye Shin; Eun-Kyeong Oh; Munkhsoyol Erkhembaatar; Okjin Kim; Yong-Rae Lee; Han-Jung Chae
Journal:  Lab Anim Res       Date:  2013-06-24

8.  Toward improved phosphorus efficiency in monogastrics-interplay of serum, minerals, bone, and immune system after divergent dietary phosphorus supply in swine.

Authors:  Michael Oster; Franziska Just; Kirsten Büsing; Petra Wolf; Christian Polley; Brigitte Vollmar; Eduard Muráni; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-09       Impact factor: 3.619

9.  Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency.

Authors:  Natasha Daga; Flavian Joseph
Journal:  BMJ Case Rep       Date:  2020-08-26

10.  Lower dietary phosphorus supply in pigs match both animal welfare aspects and resource efficiency.

Authors:  Michael Oster; Christian Gerlinger; Kaja Heide; Franziska Just; Luisa Borgelt; Petra Wolf; Christian Polley; Brigitte Vollmar; Eduard Muráni; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Ambio       Date:  2018-01       Impact factor: 5.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.